HIV protease inhibitors and nuclear lamin processing: Getting the right bells and whistles

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 35, 2007, Pages 13857-13858

  Clarke, Steven Gerard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; FARNESYLPRELAMIN A; INDINAVIR; LAMIN A; LOPINAVIR; NELFINAVIR; PROTEIN ZMPSTE24; PROTEINASE INHIBITOR; SAQUINAVIR; TIPRANAVIR; UNCLASSIFIED DRUG; LAMININ; LAMININ A; MEMBRANE PROTEIN; METALLOPROTEINASE; ZMPSTE24 PROTEIN, HUMAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; DRUG STRUCTURE; ENZYME INHIBITION; GENE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LMNA GENE; MISSENSE MUTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM;

ANIMALS; CELL NUCLEUS; HIV PROTEASE INHIBITORS; HUMANS; LAMININ; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES;

EID: 35348814977     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0706529104     Document Type: Note

References (20)

1. Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IB, Galpin SA, Handa BK, Kay J, Krohn A, et al. (1990) Science 248:358-361.
2. Randolph JT, DeGoey DA (2004) Curr Top Med Chem 4:1079-1095.
3. Walmsley S (2007) J Acquir Immune Defic Syndr 45:S5-S13.
4. Coffinier C, Hudon SE, Farber EA, Chang SY, Hrycyna CA, Young SG, Fong LG (2007) Proc Natl Acad Sci USA 104:13432-13437.
5. Hernick M, Fierke CA(2005) Arch Biochem Biophys 433:71-84.
6. Rusinol AE, Sinensky MS (2006) J Cell Sci 119:3265-3272.
7. Mazereeuw-Hautier J, Wilson LC, Mohammed S, Smallwood D, Shackleton S, Atherton DJ, Harper JI (2007) Br J Dermatol 156:1308-1314.
8. Young SG, Meta M, Yang SH, Fong LG (2006) J Biol Chem 281:39741-39745.
9. Young SG, Fong LG, Michaelis S (2005) J Lipid Res 46:2531-2558.
10. Fong LG, Ng JK, Lammerding J, Vickers TA, Meta M, Cote N, Gavino B, Qiao X, Chang SY, Young SR, et al. (2006) J Clin Invest 116:743-752.
11. Caron M, Auclair M, Sterlingot H, Kornprobst M, Capeau J (2003) AIDS 17:2437-2444.
12. Jacob KN, Garg A (2006) Mol Genet Metab 87:289-302.
13. Caron M, Auclair M, Donadille B, Bereziat V, Guerci B, Laville M, Narbonne H, Bodemer C, Lascols O, Capeau J, Vigouroux C (2007) Cell Death Differ, in press.
14. Brown MS, Goldstein JL (1999) Proc Natl Acad Sci USA 96:11041-11048.
15. Oldfield V, Plosker GL (2006) Drugs 66:1275-1299.
16. Jemsek JG, Arathoon E, Arlotti M, Perez C, Sosa N, Pokrovskiy V, Thiry A, Soccodata M, Noor MA, Giordano M (2006) Clin Infect Dis 42:273-280.
17. Cahn, P. Villacian J, Lazzarin A, Katlama C, Grinsztejn B, Arasteh K, Lopez P, Clumeck N, Gerstoft J, Stavrianeas N, et al. (2006) Clin Infect Dis 43:1347-1356.
18. Cote HCF, Brumme ZL, Harrigan PR (2001) J Virol 75:589-594.
19. Mitti PR, Grutter MG (2006) Curr Opin Struct Biol 16:769-775.
20. Southan C (2001) Drug Discov Today 6:681-688.